Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.
Other companies in Cue Biopharma’s space includes: Kezar Life Sciences Inc (NASDAQ:KZR), Aligos Therapeutics Inc (NASDAQ:ALGS), Atossa Therapeutics Inc (NASDAQ:ATOS), Citius Oncology Inc (NASDAQ:CTOR) and Edesa Biotech Inc (NASDAQ:EDSA).
Cue Biopharma has a consensus price target of $5.13.
The stock price for Cue Biopharma (NASDAQ: CUE) is $0.4392 last updated April 13, 2026 at 9:29 AM EDT.
There are no upcoming dividends for Cue Biopharma.
Cue Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Cue Biopharma.
Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.